Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626040 · ClinicalTrials.gov registry record
Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 178
- Enrollment target
NCT01626040 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 178 participants.
The verdict
NCT01626040 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of current standard of care Polyethylene Gylcol powder (PEG-P)colonoscopy preparation on a patient's serum electrolytes, tolerance of the prep, and how well the bowel is cleansed. The primary aim is to determine the proportion of patients with clinically significant serum electrolyte abnormalities at the time of colonoscopy and how well the prep is tolerated. Secondary objectives include: 1) how well the bowel is cleansed with this preparation, and 2) to determine the most effective way to communicate instructions about the bowel preparation with the child and family.
Interventions
- DRUG polyethylene glycol powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626040
The ClinicalTrials.gov registry entry for NCT01626040 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which polyethylene glycol powder is the first listed.
NCT01626040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626040 about?
NCT01626040 is a clinical study titled "Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children". The purpose of this study is to examine the effects of current standard of care Polyethylene Gylcol powder (PEG-P)colonoscopy preparation on a patient's serum electrolytes, tolerance of the prep, and how well the bowel is cleansed. The primary aim is to determine the proportion of patients with clin...
What is the current status of trial NCT01626040?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2012-06. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01626040?
The interventions under investigation include: polyethylene glycol powder (DRUG).
Who is sponsoring clinical trial NCT01626040?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.